A research team has developed a single-dose CRISPR-CasRx nanotherapy targeting the host enzyme cathepsin L (referred to as SCNC) that not only reduces SARS-CoV-2 viral load during acute infection but ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Part of a class of drugs known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results